These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18172732)

  • 21. Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases.
    Gårdmark T; Wester K; De la Torre M; Carlsson J; Malmström PU
    BJU Int; 2005 May; 95(7):982-6. PubMed ID: 15839918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus.
    Walker F; Abramowitz L; Benabderrahmane D; Duval X; Descatoire V; Hénin D; Lehy T; Aparicio T
    Hum Pathol; 2009 Nov; 40(11):1517-27. PubMed ID: 19716155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the apoptosis inhibitor protein Survivin in primary laryngeal carcinoma and cervical lymph node metastasis.
    Marioni G; Bertolin A; Giacomelli L; Marchese-Ragona R; Savastano M; Calgaro N; Marino F; De Filippis C; Staffieri A
    Anticancer Res; 2006; 26(5B):3813-7. PubMed ID: 17094406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential spatial expression and activation pattern of EGFR and HER2 in human breast cancer.
    Fink-Retter A; Gschwantler-Kaulich D; Hudelist G; Mueller R; Kubista E; Czerwenka K; Singer CF
    Oncol Rep; 2007 Aug; 18(2):299-304. PubMed ID: 17611648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-met overexpression in supraglottic laryngeal squamous cell carcinoma and its relation to lymph node metastases.
    Yücel OT; Sungur A; Kaya S
    Otolaryngol Head Neck Surg; 2004 Jun; 130(6):698-703. PubMed ID: 15195055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of EGFR, HER2, HER3, and HER4 in metastatic squamous cell carcinomas of the oral cavity and base of tongue.
    Ekberg T; Nestor M; Engström M; Nordgren H; Wester K; Carlsson J; Anniko M
    Int J Oncol; 2005 May; 26(5):1177-85. PubMed ID: 15809707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placental site trophoblastic tumor: lymphatic spread and possible target markers.
    Lan C; Li Y; He J; Liu J
    Gynecol Oncol; 2010 Mar; 116(3):430-7. PubMed ID: 19910023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent overexpression of ErbB--receptor family members in brain metastases of non-small cell lung cancer patients.
    Berghoff AS; Magerle M; Ilhan-Mutlu A; Dinhof C; Widhalm G; Dieckman K; Marosi C; Wöhrer A; Hackl M; Zöchbauer-Müller S; Preusser M; Birner P
    APMIS; 2013 Dec; 121(12):1144-52. PubMed ID: 23756255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies.
    Weinberger PM; Yu Z; Kowalski D; Joe J; Manger P; Psyrri A; Sasaki CT
    Arch Otolaryngol Head Neck Surg; 2005 Aug; 131(8):707-11. PubMed ID: 16103303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential ErbB receptor expression and intracellular signaling activity in lung adenocarcinomas and squamous cell carcinomas.
    López-Malpartida AV; Ludeña MD; Varela G; García Pichel J
    Lung Cancer; 2009 Jul; 65(1):25-33. PubMed ID: 19046792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ErbB 1-4 expression alterations in primary colorectal cancers and their corresponding metastases.
    Ljuslinder I; Malmer B; Isaksson-Mettävainio M; Oberg A; Henriksson R; Stenling R; Palmqvist R
    Anticancer Res; 2009 May; 29(5):1489-94. PubMed ID: 19443355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.
    Yamashita H; Murakami N; Asari T; Okuma K; Ohtomo K; Nakagawa K
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1165-72. PubMed ID: 19101092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
    Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
    Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas.
    Cavalot A; Martone T; Roggero N; Brondino G; Pagano M; Cortesina G
    Head Neck; 2007 Jul; 29(7):655-64. PubMed ID: 17315173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical expression and significance of epidermal growth factor receptor (EGFR) in breast cancer.
    Meche A; Cîmpean AM; Raica M
    Rom J Morphol Embryol; 2009; 50(2):217-21. PubMed ID: 19434314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic significance of human epidermal growth factor receptor correlations in squamous cell cervical carcinoma.
    Fuchs I; Vorsteher N; Bühler H; Evers K; Sehouli J; Schaller G; Kümmel S
    Anticancer Res; 2007; 27(2):959-63. PubMed ID: 17465227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
    Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PC cell-derived growth factor overexpression promotes proliferation and survival of laryngeal carcinoma.
    Kong WJ; Zhang SL; Chen X; Zhang S; Wang YJ; Zhang D; Sun Y
    Anticancer Drugs; 2007 Jan; 18(1):29-40. PubMed ID: 17159500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.
    Micozkadioğlu D; Unal M; Pata YS; Baştürk M; Cinel L
    Med Sci Monit; 2008 Jun; 14(6):CR299-304. PubMed ID: 18509272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.